Annual Report

Overview

The report describes FY2021-22 revenue from continuing operations of Rs.599.24 crores and an employee strength of 2,588 at year-end. It records Rs.65 lakhs of CSR spending for COVID-19 containment. The year also included the approved transfer of the Human Pharma Division for Rs.805 crores, subject to customary adjustments.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2021-2022
Period: Ends 31 March 2022
Language: English
Pages
File size

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services